Ratings LANXESS AG

Equities

LXS

DE0005470405

Market Closed - Xetra Other stock markets 09:05:03 26/04/2024 pm IST			5-day change	1st Jan Change
25.77 ^EUR	+0.04%		-0.31%	-9.16%

26/04	LANXESS AG : Barclays reiterates its Neutral rating	ZD
19/04	LANXESS AG : Berenberg reiterates its Buy rating	ZD

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation
The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company's share price in relation to its net book value makes it look relatively cheap.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
The company is in debt and has limited leeway for investment
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past twelve months, analysts' opinions have been revised negatively.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
LANXESS AG	-9.16%	2.38B	A
SHIN-ETSU CHEMICAL CO., LTD.	-0.19%	74.89B	B
BASF SE	+0.09%	46.52B	A-
DUPONT DE NEMOURS, INC.	-4.19%	30.82B	C
PIDILITE INDUSTRIES LIMITED	+9.85%	18.19B	B
BRENNTAG SE	-10.05%	11.54B	B
EASTMAN CHEMICAL COMPANY	+6.39%	11.24B	A-
SYENSQO SA/NV	-8.09%	9.73B	-
ASAHI KASEI CORPORATION	+2.79%	9.4B	A-
SRF LIMITED	+6.35%	9.37B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes